CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Ocular Therapeutix Inc - OCUL CFD

8.99
0.33%
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-0.24)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.02)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 50.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 8.96
Open 9.01
1-Year Change 130.43%
Day's Range 8.91 - 9.17
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 8.99 0.22 2.51% 8.77 9.17 8.77
Dec 16, 2024 8.96 0.29 3.34% 8.67 9.06 8.63
Dec 13, 2024 8.67 -0.12 -1.37% 8.79 8.99 8.59
Dec 12, 2024 8.86 -0.56 -5.94% 9.42 9.42 8.84
Dec 11, 2024 9.52 0.14 1.49% 9.38 9.63 9.25
Dec 10, 2024 9.42 0.23 2.50% 9.19 9.47 9.19
Dec 9, 2024 9.33 -0.30 -3.12% 9.63 9.73 9.10
Dec 6, 2024 9.59 0.36 3.90% 9.23 9.64 9.09
Dec 5, 2024 9.17 -0.18 -1.93% 9.35 9.54 9.12
Dec 4, 2024 9.45 0.11 1.18% 9.34 9.70 9.34
Dec 3, 2024 9.47 -0.22 -2.27% 9.69 10.18 9.38
Dec 2, 2024 9.74 0.02 0.21% 9.72 10.10 9.72
Nov 29, 2024 9.87 -0.17 -1.69% 10.04 10.13 9.70
Nov 27, 2024 10.04 0.41 4.26% 9.63 10.11 9.26
Nov 26, 2024 9.72 0.69 7.64% 9.03 9.84 9.03
Nov 25, 2024 9.06 0.23 2.60% 8.83 9.10 8.74
Nov 22, 2024 8.80 0.29 3.41% 8.51 8.84 8.33
Nov 21, 2024 8.49 -0.22 -2.53% 8.71 8.78 8.19
Nov 20, 2024 8.74 -0.12 -1.35% 8.86 8.87 8.54
Nov 19, 2024 8.90 0.39 4.58% 8.51 8.93 8.49

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
Leverage
2:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Ocular Therapeutix Inc Company profile

About Ocular Therapeutix Inc

Ocular Therapeutix, Inc. is a biopharmaceutical company, which is focused on the formulation, development and commercialization of therapies for diseases and conditions of the eye using its proprietary, bioresorbable hydrogel platform technology. The Company’s product pipeline candidates provide differentiated drug delivery solutions. The Company’s products include dexamethasone insert (DEXTENZA) and ReSure Sealant. Its DEXTENZA is an intracanalicular insert for the treatment of post-surgical ocular inflammation and pain. Its ReSure Sealant is an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery. The Company’s products that are in pipeline include OTX-TKI for the treatment of wet AMD, OTX-TIC for the treatment of glaucoma and ocular hypertension, OTX-CSI for the chronic treatment of dry eye disease, and OTX-DED for the short-term treatment of the signs and symptoms of dry eye disease.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Ocular Therapeutix Inc revenues increased from $17.4M to $43.5M. Net loss decreased 96% to $6.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Change in fair value of derivative liab. increase from $86.2M (expense) to $78.1M (income), Interest Expense decrease of 1% to $6.7M (expense).

Industry: Pharmaceuticals (NEC)

24 Crosby Drive
BEDFORD
MASSACHUSETTS 01730
US

People also watch

BTC/USD

104,972.70 Price
-1.240% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,644.96 Price
+0.040% 1D Chg, %
Long position overnight fee -0.0055%
Short position overnight fee -0.0027%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

22,032.80 Price
+0.280% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

ETH/USD

3,866.61 Price
-1.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading